Short answer · Medically reviewed summary · Last updated: 2026-05-08
Blepharophimosis Ptosis Epicanthus Inversus Syndrome (BPES) is a hereditary condition primarily caused by mutations in the FOXL2 gene. It follows an autosomal dominant inheritance pattern, meaning that an affected parent has a 50% chance of passing the condition to each child, though many cases also arise from spontaneous, de novo mutations. Is BPES hereditary and how is it inherited? Blepharophimosis Ptosis Epicanthus Inversus Syndrome is a genetic disorder, meaning it is caused by changes in an individual's DNA.
Is BPES - Blepharophimosis Ptosis Epicanthus Inversus Syndrome hereditary?
Is BPES - Blepharophimosis Ptosis Epicanthus Inversus Syndrome hereditary? The genetic component explained in plain language, reviewed against medical sources, with patient experiences.
Blepharophimosis Ptosis Epicanthus Inversus Syndrome (BPES) is a hereditary condition primarily caused by mutations in the FOXL2 gene. It follows an autosomal dominant inheritance pattern, meaning that an affected parent has a 50% chance of passing the condition to each child, though many cases also arise from spontaneous, de novo mutations.
Is BPES hereditary and how is it inherited?
Blepharophimosis Ptosis Epicanthus Inversus Syndrome is a genetic disorder, meaning it is caused by changes in an individual's DNA. It is considered hereditary because the FOXL2 gene mutation can be passed from parent to child in an autosomal dominant manner. However, it is important to note that because the condition can also occur due to de novo (spontaneous) mutations, a person may be the first in their family to be diagnosed with Blepharophimosis Ptosis Epicanthus Inversus Syndrome.
What is the risk of passing BPES to children?
For individuals with Blepharophimosis Ptosis Epicanthus Inversus Syndrome who have a known FOXL2 mutation, the inheritance risks are as follows:
- Autosomal Dominant inheritance: There is a 50% probability that each pregnancy will result in a child inheriting the mutation.
- Variable expressivity: Even within families, the severity of Blepharophimosis Ptosis Epicanthus Inversus Syndrome symptoms can vary significantly between affected individuals.
- De novo mutations: Approximately 50% of cases are estimated to be sporadic, occurring in individuals with no family history of the condition.
When is genetic testing and counseling recommended?
Genetic testing for Blepharophimosis Ptosis Epicanthus Inversus Syndrome is highly recommended to confirm a clinical diagnosis and to provide accurate reproductive information. Genetic counseling is essential for families to understand the specific risks, discuss prenatal diagnostic options, and review the potential impact of the condition, which may include premature ovarian insufficiency in females with certain Blepharophimosis Ptosis Epicanthus Inversus Syndrome genotypes.
Next steps
- Consult with a clinical geneticist to discuss molecular testing of the FOXL2 gene.
- Connect with the 70 members of the Blepharophimosis Ptosis Epicanthus Inversus Syndrome community at DiseaseMaps.org for peer support.
- Discuss family planning and reproductive options with a genetic counselor.
Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): BPES
- Orphanet: Blepharophimosis-ptosis-epicanthus inversus syndrome
- OMIM (Online Mendelian Inheritance in Man): FOXL2 gene and BPES
